Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
An Integrated Platform for Fully Automated, Continuous, & Real-Time Multi-Attributes Monitoring of Upstream Processes for Glycosylated Monoclonal Antibodies Production
Machine Learning Approaches to Characterization and Root-Cause Analysis of Particulates Formed During Protein Formulation Fill-Finish Operations
Continuous Countercurrent Spiral Chromatography (CCSC) – Feasibility, Demonstration and Commercialization